Study into prophylaxis treatment meets key endpoints

Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A - News - PharmaTimes

Related Keywords

Anders Ullman ,Dietmar Berger ,Global Head Of Development ,Swedish Orphan Biovitrum ,Global Head ,Sanofi ,Prophylaxis ,